(Q37349685)

19 August 2017

1 reference

title

Chemokine receptor antagonists: overcoming developmental hurdles (English)

1 reference

19 August 2017

Richard Horuk

1

1 reference

19 August 2017

12 December 2008

1 reference

Nature Reviews Drug Discovery

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

23-33

1 reference

19 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2734

19 August 2017

0 references

cites work

Chemokines and disease

1 reference

Drug discovery: playing dirty

31 March 2020

1 reference

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

31 March 2020

1 reference

How many drug targets are there?

31 March 2020

1 reference

31 March 2020

1 reference

Piperazinyl CCR1 antagonists--optimization of human liver microsome stability.

31 March 2020

1 reference

Blockade of chemokine signaling in patients with multiple sclerosis

31 March 2020

1 reference

11th annual Inflammatory and Immune Diseases Drug Discovery and Development Summit 12-13 March 2007, San Francisco, USA.

31 March 2020

1 reference

Advances in Anti-Inflammatory Therapeutics: 20-21 November 2006, London, UK

31 March 2020

1 reference

Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

31 March 2020

1 reference

Chemokine receptor expression in rat adjuvant-induced arthritis

31 March 2020

1 reference

Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis

31 March 2020

1 reference

Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo

31 March 2020

1 reference

Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis

31 March 2020

1 reference

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

31 March 2020

1 reference

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

31 March 2020

1 reference

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

31 March 2020

1 reference

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

31 March 2020

1 reference

Chemokines and their receptors in allograft rejection

31 March 2020

1 reference

Chemokines in rheumatic diseases

31 March 2020

1 reference

The many roles of chemokines and chemokine receptors in inflammation

31 March 2020

1 reference

The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats

31 March 2020

1 reference

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

31 March 2020

1 reference

Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.

31 March 2020

1 reference

Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis

31 March 2020

1 reference

Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders

31 March 2020

1 reference

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

31 March 2020

1 reference

Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation

31 March 2020

1 reference

Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation

31 March 2020

1 reference

Biological activity C-X-C and C-C chemokines on leukocyte subpopulations in human whole blood

31 March 2020

1 reference

Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.

31 March 2020

1 reference

Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor

31 March 2020

1 reference

Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease.

31 March 2020

1 reference

Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta

31 March 2020

1 reference

Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis

31 March 2020

1 reference

Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists

31 March 2020

1 reference

Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis

31 March 2020

1 reference

EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis

31 March 2020

1 reference

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

31 March 2020

1 reference

Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis

31 March 2020

1 reference

The hyperacute form of allergic encephalomyelitis produced in rats without the aid of pertussis vaccine.

31 March 2020

1 reference

Animal models of psoriasis

31 March 2020

1 reference

Misbehaving macrophages in the pathogenesis of psoriasis

31 March 2020

1 reference

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation

31 March 2020

1 reference

CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases

31 March 2020

1 reference

The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice

31 March 2020

1 reference

31 March 2020

1 reference

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

31 March 2020

1 reference

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

31 March 2020

1 reference

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial

31 March 2020

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

31 March 2020

1 reference

Chemokine inhibition in inflammatory arthritis

31 March 2020

1 reference

Protection from pulmonary fibrosis in the absence of CCR2 signaling

31 March 2020

1 reference

Chemokine/chemokine receptor nomenclature

31 March 2020

1 reference

31 March 2020

1 reference

Interfering with chemokines and chemokine receptors as potential new therapeutic strategies

31 March 2020

1 reference

From magic bullets to designed multiple ligands

31 March 2020

1 reference

Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists

31 March 2020

1 reference

Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics

31 March 2020

1 reference

Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension

31 March 2020

1 reference

Is there a 'lock' for all agonist 'keys' in 7TM receptors?

31 March 2020

1 reference

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints

31 March 2020

1 reference

The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle

31 March 2020

1 reference

G protein-coupled receptors. I. Diversity of receptor-ligand interactions.

31 March 2020

1 reference

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

31 March 2020

1 reference

Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation

31 March 2020

1 reference

Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.

31 March 2020

1 reference

Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.

31 March 2020

1 reference

Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist

31 March 2020

1 reference

A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

31 March 2020

1 reference

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

31 March 2020

1 reference

Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety

31 March 2020

1 reference

Evaluation of a series of bicyclic CXCR2 antagonists

31 March 2020

1 reference

Chemokines and leukocyte traffic

31 March 2020

1 reference

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

31 March 2020

1 reference

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats

31 March 2020

1 reference

Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist

31 March 2020

1 reference

Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist

31 March 2020

1 reference

A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation

31 March 2020

1 reference

Beneficial effects of targeting CCR5 in allograft recipients

31 March 2020

1 reference

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

31 March 2020

1 reference

Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection

31 March 2020

1 reference

Chemokines: a new classification system and their role in immunity

31 March 2020

1 reference

The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia

31 March 2020

1 reference

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

31 March 2020

1 reference

Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.

31 March 2020

1 reference

Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes

31 March 2020

1 reference

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

31 March 2020

1 reference

Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors

31 March 2020

1 reference

Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant

31 March 2020

1 reference

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

31 March 2020

1 reference

Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.

31 March 2020

1 reference

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

31 March 2020

1 reference

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

31 March 2020

1 reference

31 March 2020

HIV entry inhibitors.

1 reference

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

31 March 2020

1 reference

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

31 March 2020

1 reference

Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists

31 March 2020

1 reference

CCR1 antagonists for the treatment of autoimmune diseases

31 March 2020

1 reference

12 December 2020

Advances in HIV therapeutics: the 14th CROI

1 reference

12 December 2020

Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance

1 reference

12 December 2020

An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis

1 reference

12 December 2020

International union of pharmacology. XXII. Nomenclature for chemokine receptors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD2734

1 reference

19 August 2017

1 reference

PubMed ID

19079127